Prelude Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,666
| Closed | -$16K | – | 1739 |
|
|
2020
Q3 | $16K | Buy |
+1,666
| New | +$16K | ﹤0.01% | 1043 |
|
|
2020
Q1 | – | Sell |
-2,584
| Closed | -$24K | – | 1720 |
|
|
2019
Q4 | $24K | Sell |
2,584
-916
| -26% | -$8.51K | ﹤0.01% | 1116 |
|
|
2019
Q3 | $21K | Buy |
3,500
+2,696
| +335% | +$16.2K | ﹤0.01% | 935 |
|
|
2019
Q2 | $10K | Buy |
+804
| New | +$10K | ﹤0.01% | 1025 |
|
|
2018
Q4 | – | Sell |
-711
| Closed | -$11K | – | 1846 |
|
|
2018
Q3 | $11K | Sell |
711
-983
| -58% | -$15.2K | ﹤0.01% | 1089 |
|
|
2018
Q2 | $29K | Buy |
+1,694
| New | +$29K | ﹤0.01% | 1011 |
|
|
2017
Q4 | – | Sell |
-700
| Closed | -$10K | – | 1673 |
|
|
2017
Q3 | $10K | Buy |
+700
| New | +$10K | ﹤0.01% | 1308 |
|
|
2017
Q2 | – | Sell |
-1,000
| Closed | -$17K | – | 1831 |
|
|
2017
Q1 | $17K | Sell |
1,000
-6,100
| -86% | -$104K | ﹤0.01% | 1229 |
|
|
2016
Q4 | $73K | Buy |
7,100
+3,900
| +122% | +$40.1K | 0.01% | 893 |
|
|
2016
Q3 | $32K | Buy |
3,200
+700
| +28% | +$7K | ﹤0.01% | 1135 |
|
|
2016
Q2 | $28K | Buy |
2,500
+900
| +56% | +$10.1K | ﹤0.01% | 1127 |
|
|
2016
Q1 | $22K | Sell |
1,600
-1,300
| -45% | -$17.9K | ﹤0.01% | 1028 |
|
|
2015
Q4 | $55K | Buy |
+2,900
| New | +$55K | 0.01% | 959 |
|
|
2015
Q1 | – | Sell |
-1,400
| Closed | -$19K | – | 2150 |
|
|
2014
Q4 | $19K | Sell |
1,400
-1,700
| -55% | -$23.1K | ﹤0.01% | 1652 |
|
|
2014
Q3 | $39K | Buy |
+3,100
| New | +$39K | 0.01% | 1377 |
|